Open menu

INTELLIGENZA ARTIFICIALE IN AMBITO SANITARIO E FARMACEUTICO

Ultimi articoli di sintesi (max 100) delle evidenze scientifiche (review, revisioni sistematiche e metanalisi). pubblicate su riviste indicizzate in Pub Med, su questo argomento
Intelligenza artificiale in ambito sanitario intelligence drug: Latest results from PubMed
  1. We reviewed artificial intelligence and machine learning in magnetic resonance imaging-visible magnetic nanoparticles, nanocarriers, and systems for imaging, drug delivery, hyperthermia, targeting, transport, and control. Using "preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020" methods, 2,283 records from seven databases yielded 65 studies. Predicted outcomes were colloidal stability, toxicity, uptake, magnetic descriptors, specific absorption rate, relaxivity,...
  2. CONCLUSIONS: Data heterogeneity and algorithmic bias are the primary constraints on AI/ML-based AMR prediction, not algorithmic sophistication. The strong internal performance metrics reported across the literature do not reliably generalize to diverse populations, geographic settings, or clinical environments. Meaningful progress requires a deliberate shift in research priorities toward globally representative datasets, harmonized laboratory standards, mandatory external validation, and...
  3. CONCLUSION: Telepharmacy-based mHealth applications with active pharmacist involvement may contribute to improving comprehensive diabetes management. However, evidence is currently limited. Future applications should prioritise user-centred design, sustainable engagement strategies, and supportive policy frameworks.
  4. Digital twins (DTs) have made a significant impact on many industrial sectors, including healthcare and biomedicine, where they are being applied to patient-specific digital twinning, personalised medicine, predictive diagnostics, and surgical planning. While the literature is sparse, studies are emerging, with a particular focus on dermatology because many skin-related issues are inherently multimodal, longitudinal, and patient-specific. This has led to the development of cutaneous digital...
  5. CONCLUSIONS: Current disclosure instruments ask whether AI wrote the text. Reviewers need to know whether AI selected the evidence, defined the cohort, derived the endpoint, or generated the code, and whether the recommendation would change without it.
  6. Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease imposing a substantial health and economic burden. Artificial intelligence (AI) has emerged as a promising tool to address CRS complexity in both clinical and research settings. We conducted a systematic review following PRISMA guidelines, searching PubMed, Web of Science, and Embase for peer-reviewed articles utilizing machine learning, deep learning, and natural language processing, with a focus on molecular-level or...
  7. CONCLUSIONS: hile ML shows promise in predicting the therapeutic effects of anti-TNF-α treatment in individuals with CD, there are some methodological limitations. Future research should integrate multi-center, geographically diverse datasets to enhance the generalizability of models. Improving model robustness will help identify non-responders early, ultimately promoting the development of personalized therapeutic strategies and precision medicine.
  8. CONCLUSIONS: Digital health technologies show potential for antimicrobial stewardship in menopausal women with urinary tract infections but remain largely insensitive to menopause-specific biological factors. One randomised controlled trial demonstrated increased uptake of vaginal oestrogen therapy with the use of these technologies, providing evidence of digitally supported non-antibiotic prevention. Future research should integrate menopausal staging, hormonal variables, and user-centred...
  9. CONCLUSION: In available aggregate real-world data, AB cohorts reported higher median PFS and disease control than DT cohorts, whereas OS could not be reliably compared. Marked differences in treatment line, age, calendar period, and covariate support, together with the small DT evidence base, preclude reliable comparative-effectiveness inference.
  10. Accurate prediction of time-to-event outcomes is essential for clinical decision-making and model-informed drug development (MIDD). Conventional survival models may inadequately represent complex longitudinal patient trajectories, time-dependent treatments, and evolving biomarker or pharmacokinetic/pharmacodynamic (PK/PD) profiles. Recent advances in machine learning (ML) and deep learning (DL) have enabled dynamic survival models that update individualized risk predictions as new longitudinal...
  11. CONCLUSION: To overcome the challenges of AI application in the Asia-Pacific, a tiered implementation strategy can be employed through establishing a regional collaboration framework and taking into account disparities in technological maturity across countries.
  12. CONCLUSIONS: AI has significant potential to enhance nanoparticle formulation optimization, biodistribution modeling, and toxicity prediction. Nevertheless, translation into clinical practice remains constrained by small datasets, limited external validation, and inconsistent reporting standards. Future research should prioritize standardized datasets, transparent AI models, and prospective validation to advance AI-enabled nanomedicine toward clinical implementation.
  13. CONCLUSION: Machine learning models exhibit outstanding diagnostic accuracy in predicting AMR in Neisseria gonorrhoeae, highlighting their potential integration into surveillance and clinical decision-support systems. Broader validation and standardization of ML pipelines are essential to translate these advances into global public health practice.
  14. BACKGROUND: Optimization of renal drug dosing to avoid drug toxicity is essential in Chronic Kidney Disease (CKD), yet prescribing errors are common. CDSS with rule-based and AI/ML based tools are used to address this safety gap; however, their impact remains uncertain.
  15. CONCLUSIONS: Current evidence did not demonstrate a statistically significant reduction in overall hypoglycaemia, treatment failure, recurrent hypoglycaemia, NICU admission or breastfeeding interruption after administration of oral 40% dextrose compared with control. While safe and low-cost, current evidence does not support routine use as a standalone intervention. Heterogeneity across protocols and populations warrants standardization in future trials.
  16. CONCLUSIONS: While stochastic and generative models offer enhanced predictive capacity for DDI detection, current evidence does not demonstrate a proportional improvement in clinically reliable decision support. Deterministic systems provide transparency and safety constraints but lack adaptability to patient-specific contexts. Future interventions must prioritize hybrid architectures that integrate explainable rule-based guardrails with rigorously validated stochastic models to ensure that...
  17. Colorectal cancer (CRC) has shown significant heterogeneity regarding its response to immunotherapy. Long-lasting, beneficial effects have been observed in mismatch repair-deficient, microsatellite instability-high (dMMR/MSI-H) tumours, while mismatch repair-proficient, microsatellite stable (pMMR/MSS) tumours have remained resistant. Such differences in results have been studied in this review through the "hot" and "cold" tumour concept. It explains how various biological and microenvironmental...
  18. CONCLUSION: AI has matured from methodological exploration into a robust clinical decision-support tool for SLE, particularly for lupus nephritis assessment and flare prediction. Future advancements rely on conducting prospective clinical validations in real-world cohorts, predicting personalized drug efficacies, and leveraging multi-omics to decode pathological mechanisms. These steps are essential to transition SLE management from traditional empirical approaches to data-driven precision...
  19. Rheumatoid arthritis (RA) is a highly prevalent systemic autoimmune disease characterized by a complex and partially understood pathogenesis. The substantial challenges in early identification and marked therapeutic heterogeneity pose a significant burden on affected patients. Despite notable advancements in diagnostic techniques and therapeutic interventions in recent years, optimal patient care remains hindered by several ongoing clinical challenges. To address these limitations, artificial...
  20. CONCLUSION: ML-assisted pharmacovigilance enables a shift from passive to active, intelligent monitoring. Despite challenges in data quality, model interpretability, and regulatory approval, intelligent pharmacovigilance systems will become essential infrastructure for safeguarding public health.
  21. BACKGROUND: Despite advances in epilepsy treatment options, selecting the appropriate therapy for an individual with epilepsy is a process of trial and error. Machine learning holds the potential to support clinical decision making. We aimed to provide an overview of the role of machine learning in epilepsy management and discuss future directions.
  22. CONCLUSION: Curcumin exerts potent, multi-target osteoprotective effects that are associated with improved bone remodeling and oxidative stress-related indices. The exploratory integration of ML with meta-analysis suggested that biological characteristics and dosage may contribute to variability in treatment effects. However, because the ML component was constrained by the limited number of study-level observations, these model-derived findings should be regarded as hypothesis-generating signals...
  23. Marzouk et al. reviewed 147 studies on artificial intelligence (AI) applications for predicting drug-drug, drug-disease, and drug-nutrient interactions, providing a broad overview of current machine learning and deep-learning approaches. However, several methodological and conceptual limitations reduce the reproducibility and interpretability of the review. The search strategy appears largely restricted to PubMed with title- and abstract-level filtering, while manual record removal is reported...
  24. CONCLUSIONS: Across 17 studies, AI models demonstrated moderate to good discrimination for predicting NAC response in gastric cancer, with pooled AUCs of 0.844 (95% CI 0.812 to 0.877) for internal validation and 0.812 (95% CI 0.775 to 0.848) for external validation. Model-methodology subgroup analyses did not demonstrate robust differences between deep learning and machine-learning approaches, and AI models significantly outperformed traditional clinical assessment. However, GRADE-rated...
  25. CONCLUSIONS: AI/ML models for predicting TB treatment failure show promising discrimination but are not yet ready for routine clinical implementation. Performance varies substantially across populations and settings, and methodological limitations, including inadequate validation, poor calibration assessment, and high risk of bias, limit confidence in current estimates. Future research should prioritize rigorous external validation, calibration assessment, and development in underrepresented...
  26. Background/Objectives: Pharmacovigilance workflows rely heavily on unstructured text across diverse sources. Here, we systematically reviewed how large language models (LLMs) are being explored as support tools for adverse drug reaction (ADR) detection, extraction, triage, and documentation, highlighting their potential for precision medicine and big data-enabled safety monitoring. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, we...
  27. CONCLUSIONS: FDA/CE-cleared AI systems demonstrate promising diagnostic performance in breast screening. The strongest evidence supports workflow configurations that reduce radiologist workload, particularly triage and independent/supporting reader models, while prospective evidence supporting complete replacement of radiologists remains lacking.
  28. CONCLUSION: This study conducted a systematic bibliometric evaluation of pediatric NS, and clarified its current research status and identified future research hotspots and development trends. The exploration of novel immunosuppressants and the elucidation of complex pathogenic mechanisms remain enduring hotspots in the evolving landscape of pediatric NS.
  29. Reliable prediction of nanoparticle (NP) transport across the blood-brain barrier (BBB) is essential for designing effective central nervous system-targeted drug delivery systems. The BBB protects the brain but severely restricts the entry of therapeutic compounds, and fewer than 5% of candidate drugs reach the brain in pharmacologically meaningful amounts. NP-based delivery systems have emerged as a promising approach to overcome this limitation by enhancing drug stability, circulation, and BBB...
  30. CONCLUSIONS: The adoption of classical AI tools in BD serves as a driver for therapeutic optimization, although current AI tools in BD should still be considered exploratory rather than ready for clinical use. Effective implementation in real-world clinical scenarios requires more robust, transparent, and externally validated models to ensure reliability and generalizability.
  31. CONCLUSIONS: Non-suicidal cases of SS during regular prescription were less serious than SS cases associated with intentional overdose. The emerging role of non-antidepressant agents (e.g., several opioids and antiparkinsonian drugs) as potential precipitants support tailored interprofessional medication review in poly-medicated subjects.
  32. CONCLUSIONS: While AI tools in cardiology show increasing promise, current HTA practices do not yet fully align with the regulatory and methodological expectations of the EU HTAR. Adapted evaluation models are needed to support the effective, evidence-based adoption of AI technologies in cardiovascular care.
  33. Neurological disorders refer to a diverse group of conditions that affect the brain, peripheral nerves, and spinal cord and impair socioemotional, cognitive, motor, and sensory functions. Alzheimer's disease (AD), Multiple Sclerosis (MS), Parkinson's disease (PD), Huntington's disease (HD), and Amyotrophic Lateral Sclerosis (ALS) are some of the well-known neurodegenerative diseases that affect millions of people worldwide. Despite the advanced technologies and nano-drug delivery systems, the...
  34. CONCLUSIONS: This review is the first to synthesize and quantitatively compare skeletal outcomes across multiple biologics in OI with an AI-assisted review workflow. Denosumab and setrusumab demonstrate promising efficacy in improving lumbar spine aBMD across ages, although current evidence does not support superior fracture reduction over bisphosphonates. GPT-4o can substantially accelerate evidence synthesis but should be deployed with explicit human oversight in tasks requiring contextual...
  35. CONCLUSIONS: Imaging modality and algorithm model are key factors influencing AI prediction models for PD-L1 expression in NSCLC patients.
  36. CONCLUSIONS: AI-based models demonstrate promising accuracy for predicting pCR after NAST in eTNBC, but their clinical applicability is limited by substantial heterogeneity, inconsistent validation strategies, and potential publication bias. Prospective multicenter studies with standardized reporting and robust external validation are mandatory before routine clinical implementation.
  37. CONCLUSION: Proactive identification and rigorous management of hyperglycaemia and/or T2D are essential to reducing complications and improving outcomes in women with BC receiving chemotherapy. Evidence demonstrates that poor glycaemic control clearly impairs treatment response. The current research gap and fragmented care pathways demand strengthened multidisciplinary collaboration and the delivery of personalised care. These measures are necessary to significantly improve the quality of living...
  38. INTRODUCTION: Vascular malformations are a group of congenital vascular developmental anomalies. According to the International Society for the Study of Vascular Anomalies classification, they are mainly divided into Slow-Flow and Fast-Flow lesions. Slow-Flow lesions are represented by venous malformations, lymphatic malformations, and capillary malformations; Fast-Flow lesions primarily include arteriovenous malformations and arteriovenous fistulae. As a minimally invasive interventional...
  39. CONCLUSION: Semen Cuscutae exerts robust osteoprotective effects via coupled anti-inflammatory and osteogenic mechanisms. The exploratory ML-derived ranking suggests that species-specific dose scaling and treatment duration may be important considerations for future preclinical and translational studies of Semen Cuscutae.
  40. CONCLUSION: Leprosy should be considered in the differential diagnosis of SLE, particularly in patients presenting with cutaneous and articular manifestations accompanied by peripheral neuropathy and poor response to immunosuppressive therapy. By delineating recurring clinical patterns and diagnostic pitfalls, our findings provide practical clues for earlier recognition, helping to prevent diagnostic delay, inappropriate immunosuppression, and adverse outcomes.
  41. CONCLUSIONS: ACEIs and beta blockers appear to confer modest cardioprotective effects during chemotherapy, particularly regarding systolic function and heart failure incidence, although with predominantly low-certainty evidence. Larger, robust RCTs with standardised endpoints are required before routine prophylactic use is recommended.
  42. Artificial Intelligence (AI) is increasingly applied for food quality control, authenticity assessment, and chemical profiling. However, the reliability and industrial applicability of Machine Learning (ML) and Deep Learning (DL) models critically depend on how the datasets are constructed, validated, and interpreted. Among the different analytical techniques used in food analysis, chromatographic fingerprints and chromatographic hyphenated techniques typically generate high-dimensional datasets...
  43. BACKGROUND: Disease reactivation following cessation of sphingosine 1-phosphate receptor modulators (S1PRM) occurs in ~ 10% of multiple sclerosis (MS) patients. The biological factors underlying this phenomenon remain incompletely understood, including the potential contribution of sex-specific differences.
  44. CONCLUSIONS: Intestinal capillariasis is an underrecognized foodborne infection with a consistent clinical and laboratory profile across study designs. Early diagnosis through repeated stool examination and timely treatment with benzimidazoles is critical to improving outcomes. Strengthening food safety practices and enhancing surveillance are essential to reduce disease burden.
  45. CONCLUSIONS: Approximately one in seven AF episodes occurring during BTKi therapy are asymptomatic. This proportion is influenced by the method of rhythm monitoring and may be higher when prolonged monitoring strategies are employed.
  46. CONCLUSIONS: The extent of MF is closely associated with various factors, underscoring the importance of its identification in hypertensive patients. Histology and T1 mapping parameters are effective for quantifying MF. Due to the variable effects of antihypertensive medications on MF, the use of specific agents to mitigate MF in hypertensive patients is recommended.
  47. CONCLUSIONS: Our findings demonstrate that DT technology has evolved from theoretical models to integrated clinical applications, with the potential to revolutionize healthcare through personalized medicine, continuous monitoring, and AI-driven decision support.
  48. ADP-ribosylation is a reversible post-translational modification regulated by poly(ADP-ribose) polymerases (PARPs), a family of enzymes involved in DNA repair, transcriptional regulation, and immune responses. Among the 17 known PARP family members, PARP1 is the most extensively studied in autoimmune rheumatic diseases (ARDs). Although increasing evidence implicates PARP1 in ARD pathogenesis, its potential diagnostic and therapeutic relevance has not been systematically synthesised. This...
  49. CONCLUSION: AI-based AMR prediction and detection in K. pneumoniae is advancing rapidly, with MALDI-TOF-enabled approaches appearing most readily translatable to clinical microbiology workflows. However, the field remains dominated by retrospective, internally validated studies, often using imperfect automated susceptibility systems as reference standards. Progress now depends on rigorous external and prospective multicentre validation using geographically diverse datasets.
  50. Drug-drug interactions (DDIs) pose major risks in chronic disease management where polypharmacy is common. Although digital DDI tools are used widely to aid healthcare professionals, tools rely on theoretical interactions. This limitation questions their reliability and validity for clinical relevancy. Hence, this systematic review identified available DDI tools and evaluated their reliability and validity in chronic disease management. Following PRISMA guidelines, MEDLINE, Embase, Scopus, Web...
  51. CONCLUSIONS: Machine learning represents a highly active and debated domain in anaesthesia, characterised by a substantial volume of published research. However, exceptionally few algorithmic models have successfully translated into practice-changing clinical tools. This persistent gap indicates that technical innovation alone is insufficient, as translation is severely hindered by inherent model limitations, software interoperability constraints, and socio-technical challenges within the...
  52. CONCLUSION: There is a significant opportunity for model developers and end users to identify and reduce bias, particularly during model design. When evaluating strategy effectiveness, efforts should be measured using evidenced-based fairness metrics-such as group-based metrics-to ensure effectiveness and interpretability.
  53. Invertebrate and larval model organisms such as Drosophila melanogaster, Caenorhabditis elegans, Danio rerio larvae, and Galleria mellonella are increasingly employed in biomedical, toxicological, and ecological research. Their behavioral responses serve as sensitive indicators of functional changes, yet traditional methods of observation remain low-throughput, subjective, and poorly scalable. Artificial intelligence (AI), including machine learning (ML) and deep learning (DL), has emerged as a...
  54. Background/Objectives: The integration of machine learning (ML) within model-informed drug development (MIDD) represents a rapidly evolving paradigm in pharmacometrics, enabling improved prediction, optimization, and regulatory decision-making across drug development pipelines. However, the extent to which ML methods are explicitly integrated into regulatory decision-making remains limited and unevenly characterized. This study aims to systematically map the ML-MIDD scholarly landscape, identify...
  55. CONCLUSIONS: This umbrella review found no convincing evidence that vitamin D supplementation improves asthma control, reduces exacerbations, or enhances lung function in children with asthma, despite its effect on increasing serum 25-hydroxyvitamin D levels and a possible benefit for asthma recurrence. However, these findings should be interpreted with caution, considering that the available evidence was limited by generally low methodological quality, substantial overlap among meta-analyses,...
  56. Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited effective therapies. Two-dimensional (2D) in vitro models poorly recapitulate tumor microenvironment (TME) interactions, impeding the translational relevance of TNBC immunotherapy research. Three-dimensional patient-derived tumor organoids (3D PDTOs) have emerged as advanced preclinical models that better mimic tumor-immune interactions. The objective of this systematic review was to assess the landscape...
  57. CONCLUSIONS: Traditional MI sources remain central for adult medicine users despite the growing role of electronic platforms. While the receipt of MI from electronic sources appears more common among internet-experienced users, no significant temporal trends in using these sources were identified. Further research is needed to better distinguish between different digital MI sources, including artificial intelligence-based MI sources, and to explore their evolving roles, implications for...
  58. INTRODUCTION: Drug-drug interactions (DDIs) are a major cause of preventable harm in polypharmacy and remain difficult to anticipate as formularies, indication profiles, and interaction labels evolve. Over the last few years, the DDI modeling landscape has shifted rapidly toward graph-native, multimodal, and contrastive or self-supervised learning, alongside renewed interest in extraction, decision support, and pharmacovigilance pipelines.
  59. Older adults face increased risks of medication non-adherence, adverse drug events, and polypharmacy due to chronic health conditions and complex drug regimens. Traditional medication management approaches often fall short in addressing these challenges. Artificial intelligence (AI) has emerged as a promising tool for enhancing medication safety and personalization in geriatric care. This systematic review aimed to explore the role of AI in medication management for older adults, highlighting...
  60. CONCLUSIONS: ML for comparative antidepressant selection remains in an early stage of development. Only 1 study implemented a unified framework directly supporting patient-level treatment ranking. Key barriers to clinical translation include insufficient distinction between prognostic and predictive markers, limited cross-trial validation, near-absent calibration reporting, and absent explainability. Future research should prioritize unified comparative frameworks with calibrated predictions,...
  61. Background: Ultrasonography (US) has emerged as a non-invasive method for anatomical and functional evaluation of upper airway structures in adult obstructive sleep apnea (OSA). However, its role in severity stratification, dynamic assessment, elastographic characterization, and therapeutic monitoring remain to be investigated. Background/Objectives: The goal herein is thus to systematically review and synthesize available evidence on US assessment in adults with OSA, including structural...
  62. CONCLUSION: This SRMA confirms the predominance of right-sided IE, particularly tricuspid valve involvement, in IVDUs, with a significantly higher risk compared to left-sided IE. The findings underscore the need for targeted screening, early intervention, and IVDU-specific management strategies in IE care. Future research should focus on regional variations, microbiological patterns, and long-term outcomes in this high-risk population.
  63. CONCLUSIONS: This review highlights significant variability in WOMAC pain reporting in osteoarthritis trials, affecting statistical power and trial design. Key factors influencing variability include trial design, administration route, and participant characteristics. Integrating these variability estimates into sample-size calculations can enhance the efficiency of future pain trials.
  64. Antimicrobial resistance (AMR) poses an escalating threat to global health, as multidrug-resistant pathogens undermine therapeutic efficacy and surveillance systems. Although whole-genome sequencing and phenotypic drug susceptibility testing have strengthened resistome profiling, translating multi-omics data into reliable, clinically deployable intelligence remains computationally fragmented. Following PRISMA 2020 guidelines, we systematically reviewed 156 records published between 2016 and...
  65. CONCLUSION: Given the increasing BDQ resistance and regional variability, it is essential to develop early detection systems, genomic surveillance, robust drug policy enforcement, and rapid diagnostics to maintain treatment effectiveness and curb the spread of resistance. Future research should focus on elucidating resistance mechanisms and developing novel therapeutic strategies.
  66. CONCLUSIONS: Machine learning models for predicting TB treatment failure show promising discrimination but are not yet ready for routine clinical implementation. Performance varies substantially across populations and settings, and methodological limitations, including inadequate validation, poor calibration assessment, and high risk of bias, limit confidence in current estimates. Future research should prioritize rigorous external validation, calibration assessment, and development in...
  67. CONCLUSION: Evidence from this meta-analysis suggests oral contraceptive use is associated with increased risks of depression diagnoses, antidepressant initiation, and higher depressive symptom scores. The findings, which reflect the association between hormonal oral contraceptives and depression in women without pre-existing psychological or gynaecological conditions, suggest that adverse effects on mood should be closely monitored by contraception prescribers.
  68. CONCLUSION: Exploratory single-arm analyses suggested modest short-term reductions in systolic blood pressure and suggested metabolic effects with an acceptable safety profile. However, controlled difference-in-differences analyses showed no significant blood pressure reductions versus control. Most available evidence derives from studies in which SGLT2 inhibitors were not initiated specifically for blood pressure control. Dedicated randomized controlled trials are required to determine their...
  69. CONCLUSIONS: Current hypoglycaemia prediction models for T2DM show substantial methodological limitations and high bias risk. While machine learning models have advanced rapidly in recent years, their methodology remains opaque and validation is limited. Future research should focus on optimising existing models, enhancing methodological rigour and conducting external validation.
  70. CONCLUSIONS: Depending on the field of application, some ML methods are more suitable and adapt better to certain HIV concerns. However, some areas, such as treatment recommendations, treatment adherence, and treatment optimization, still lack AI algorithms and need further exploration, such as therapeutical optimization. The development of new clinical decision-support systems for people living with HIV is the new challenge for the years ahead, and AI represents one of the most promising tools...
  71. CONCLUSIONS: Across a heterogeneous evidence base, integrating LAT into first-line EGFR TKI therapy is associated with improved progression-free survival and overall survival with acceptable toxicity. These findings support further prospective investigation to better define patient selection, optimal timing, and integration with contemporary systemic combination strategies.
  72. CONCLUSION: Reinforcement learning provides a robust framework for automated drug design, enabling intelligent exploration of chemical space and the generation of novel, bioactive compounds. However, further improvements in multi-objective optimization, computational efficiency, and model transparency are essential for broader clinical applicability. Future research should focus on hybrid RL architectures and explainable AI techniques to bridge computational and experimental drug discovery.
  73. CONCLUSIONS: To our knowledge, this is the first systematic review of AI applications specifically targeting medication adherence in BC. It focuses on both predictive and interventional studies, mapping current AI applications within this specific clinical context. The findings highlight gaps in the implementation phase and emphasize the need for future research integrating a coordinated, multidisciplinary approach involving researchers, AI specialists, policymakers, and health care teams.
  74. Indoor spaces contain diverse microbial communities that shape human health. These microorganisms are particularly relevant to respiratory diseases, including asthma and allergies. Despite growing recognition of the importance of indoor microbial exposures, research in this field is slowed by differences in methods. These inconsistencies make it difficult to compare results and draw conclusions. This systematic review analyses 106 studies published between 2000 and 2025 that investigated indoor...
  75. CONCLUSION: This bibliometric analysis thoroughly outlines the current status and developmental tendencies of TCM research in NAFLD for the first time, offering significant references for future investigations in this domain.
  76. INTRODUCTION: Artificial intelligence (AI) has increasingly been applied in pharmacoepidemiology, yet the methodological landscape of adverse drug event (ADE) prediction remains heterogeneous and insufficiently mapped.
  77. CONCLUSIONS: In individuals with type 2 diabetes, AID is associated with short-term improvements in glycemic control, although the certainty of evidence is low to moderate.
  78. CONCLUSION: Validation through prospective multicenter studies and reporting that has been standardized is the key to clinical reliability enhancement and backed-up precision oncology implementation.
  79. Diabetic kidney disease (DKD), characterized by progressive renal dysfunction, is a prevalent microvascular complication of diabetes mellitus and a leading cause of end-stage renal disease worldwide. Despite advances in glycemic and blood pressure control, the incidence and prevalence of DKD continue to escalate, posing a growing public health challenge. Extracellular vesicles, particularly exosomes, are nanometer-sized vesicles secreted by diverse cells and have emerged as key regulators of...
  80. BACKGROUND: Gender influences health outcomes by affecting exposure to risk factors, healthcare access, and health-seeking behaviours. Yet, many studies fail to consider how these gendered experiences interact with other social factors, such as age, socioeconomic status, and ethnicity. Our study systematically mapped existing research to identify gaps in understanding how these factors affect service delivery outcomes related to antimicrobial resistance (AMR) for infectious diseases of poverty....
  81. CONCLUSION: This review highlights methodological limitations hindering the clinical translation of current DL approaches for EZ localization and provides a comprehensive set of recommendations to address them. Future work should prioritize developing standardized, clinically informative evaluation frameworks and explore research avenues aligned with modern DL practices, spanning from uncertainty quantification to large-scale vision foundation models and synthetic data generation.
  82. CONCLUSIONS: Closed-loop AID significantly improves glycemic control in T2DM without increasing serious adverse events.
  83. Background. NOTCH receptors play a pivotal role in carcinogenesis. Upon ligand binding, a cascade of proteolytic cleavages mediated by ADAM proteases and the γ-secretase complex activates the receptor, ultimately releasing the NOTCH intracellular domain (NICD). NICD translocates to the nucleus, where it regulates gene expression. This review mainly aims to evaluate γ-secretase inhibitors (GSIs) as anticancer agents in preclinical and clinical settings, with a focus on their ability to block...
  84. Purpose To perform a systematic review evaluating current digital twin (DT) implementations, highlighting clinical relevance and technical strategies, and identifying opportunities to advance personalized, predictive care in neuro-oncology. Materials and Methods PubMed, Scopus, and Web of Science databases were systematically screened for English-language original research articles published from inception through June 2025 focused on DT development, validation, or patient-specific computational...
  85. CONCLUSION: Amino acid-enriched hyaluronic acid improves wrinkle severity, dermal thickness, and cell viability, enhancing overall skin aesthetics. Larger prospective studies are needed to confirm these findings.
  86. CONCLUSION: The use of perioperative SGLT2 inhibitors poses a clinical paradox between significant renoprotection and survival advantages and a latent risk of ketoacidosis concealed by considerable heterogeneity. While metabolic monitoring is essential, current surgeries requiring more prolonged withholding may need to weigh metabolic risk against the drug's significant benefit in reducing acute kidney injury and mortality.
  87. CD36 is a multifunctional glycoprotein essential in fatty acid metabolism, angiogenesis, and atherogenesis, playing a critical role in immunological processes. This comprehensive review synthesizes current research to elucidate CD36's integral functions within the immune system, including its involvement in phagocytosis, inflammation, and the crucial interplay between innate and adaptive immune responses. We highlight novel insights into CD36 as a therapeutic target, presenting recent advances...
  88. BACKGROUND: Key populations bear a disproportionate burden of hepatitis B virus (HBV). We synthesized evidence on the HBV care cascade among key populations to inform strategies toward WHO's 2030 elimination targets.
  89. Glanzmann Thrombasthenia (GT) is a congenital platelet disorder characterized by a life-long bleeding tendency, historically considered protective against thrombosis. This report describes a rare case of pulmonary embolism (PE) in a patient with GT, challenging this assumption and highlighting a critical management paradox. A 55-year-old woman with GT underwent elective cervical discectomy. Her perioperative hemostatic regimen included a single prophylactic dose of recombinant Factor VIIa (90...
  90. CONCLUSIONS: Switching patients to faricimab reduced the injection frequency by two to three injections in the first year. Although evidence certainty was limited by statistical heterogeneity, the reduction was consistent across studies. Although replacing first-line bevacizumab increases costs, substantial savings are achievable in later lines. Strategic positioning of faricimab in the second-line yields significantly higher savings compared to third-line use, and could significantly lower the...
  91. Artificial intelligence (AI) technologies are increasingly integrated into healthcare, yet their economic value remains uncertain. Traditional economic evaluation methods may not adequately capture the unique features of AI, including dynamic model evolution, scalability, and broader societal impacts. This systematic review synthesized existing evidence on the cost-effectiveness of AI-based healthcare interventions and assessed the methodological rigor of published studies. A comprehensive...
  92. A large body of work has investigated the effect of various pharmacological compounds on aversive memory formation, retrieval, and modification in humans. A broad overview across signalling pathways and memory models is currently lacking. Here, we systematically review publications that tested the impact of acute pharmacological interventions on aversive memory in healthy humans, following PRISMA-2020. We identified 215 candidate compounds from 17 systems and searched PubMed, Web of Science and...
  93. Molecular representation learning (MRL) is afoundation in leveraging computational methods for drug discovery, enabling the transformation of molecular structure and properties into numerical vectors. These vectors serve as input for machine learning models and facilitate the prediction and analysis of molecular attributes, functions, and reactions. The advent of foundation models has introduced both new opportunities and challenges to MRL. These models have improved generalizability and...
  94. Background and Objectives: IgA nephropathy represents the most prevalent form of primary glomerulonephritis around the world, with significant heterogeneity in management strategies and outcomes. We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of pharmacological interventions for IgA nephropathy. Materials and Methods: We searched multiple databases through June 2025, identifying randomized controlled trials and observational studies evaluating...
  95. CONCLUSION: TDEVs represent a paradigm shift in precision oncology for genitourinary malignancies. With advancing technologies in isolation methods, multi-omics integration, and artificial intelligence applications, TDEVs are poised to become indispensable tools for early tumor detection, real-time monitoring, and personalized therapeutic strategies, heralding a new era in uro-oncological practice.
  96. The integration of machine learning (ML) and artificial intelligence (AI) technologies into anesthesia practice represents a paradigm shift toward precision medicine by enabling automated, data-driven decision-making during surgery. This systematic review aimed to evaluate current applications of ML for automated drug titration and real-time physiologic optimization in anesthesia. A comprehensive literature search, adhering to PRISMA (Preferred Reporting Items for Systematic Reviews and...
  97. CONCLUSIONS: Although AI/ML methods show significant potential for distinguishing IBS from IBD, existing studies present limitations, including small sample sizes, data heterogeneity, and generalizability challenges. The development of standardized protocols and extensive multicenter studies is recommended to clinically validate these models, facilitating their integration into current medical practice.
  98. CONCLUSIONS: Our systematic review provides a comprehensive summary of evidence-based CPG recommendations for geriatric trauma care, offering clinicians a solid foundation for managing this vulnerable patient population.
  99. CONCLUSION: CRGNB research is increasingly directed toward elucidating resistance mechanisms, improving diagnostic tools, and exploring non-antibiotic therapeutic options. Strengthening international collaboration and fostering multidisciplinary approaches are imperative to advance high-quality research and address this growing threat.
  100. (1) Background: Post-stroke spasticity limits motor recovery and independence. Combining botulinum toxin type-A (BoNT-A) injection with intensive, task-specific robot-assisted therapy (RAT) might enhance neuroplasticity and functional gains, but its additive effect and optimal timing are uncertain. (2) Methods: We systematically searched major medical databases and trial registries up to April 2025 for randomized controlled trials in adults with post-stroke spasticity comparing botulinum toxin...